Arsenal Medical uses conventional biomaterials in unconventional ways to develop novel products that improve local therapy for injury and disease. The company is advancing multiple preclinical programs based on both its two proprietary technology platforms: its therapeutic foam and AxioCore, a novel, high-throughput nanofiber technology.ArsenalMedical is supported by venture funding, as well as grants from the Department of Defense, National Institute of Standards and Technology’s Technology Innovation Program (NIST-TIP), and the Bill & Melinda Gates Foundation. Its investors include Polaris Venture Partners, North Bridge Venture Partners, and Intersouth Partners.

Biotechnology

Health Care

Therapeutics

Arsenal Medical

Arsenal Medical

Org chart

Similar companies